Accepted for Publication: December 2, 2021.
Published: January 21, 2022. doi:10.1001/jamanetworkopen.2021.45697
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Perlis RH et al. JAMA Network Open.
Corresponding Author: Roy H. Perlis, MD, MSc, Massachusetts General Hospital, 185 Cambridge St, Sixth Floor, Boston, MA 02114 (rperlis@mgh.harvard.edu).
Author Contributions: Dr Perlis had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Perlis, Lazer, Della Volpe.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Perlis.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Perlis, Santillana.
Obtained funding: Ognyanova, Druckman, Lazer, Baum.
Administrative, technical, or material support: Ognyanova, Lin, Druckman, Lazer, Simonson, Della Volpe.
Supervision: Perlis, Lazer.
Conflict of Interest Disclosures: Dr Perlis reported receiving personal fees from Burrage Capital, Genomind, RID Ventures, Belle Artificial Intelligence, and Takeda and owning equity in Psy Therapeutics and Belle Artificial Intelligence outside the submitted work. No other disclosures were reported.
Funding/Support: This study was supported by the National Science Foundation (SES-2029292 and SES-2029792; Drs Baum and Ognyanova), the National Institute of Mental Health (R01MH116270 and 1R56MH115187; Dr Perlis), and Northeastern University, Harvard Kennedy School of Government, and Rutgers University.
Role of the Funder/Sponsor: The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclaimer: Dr Perlis is an associated editor of JAMA Network Open, but he was not involved in any of the decisions regarding review of the manuscript or its acceptance.